Insights

Innovative Cell Delivery Manifold Bio's focus on tissue-specific biologics and development of blood-brain barrier shuttles presents opportunities to partner with bioprocessing and drug delivery solution providers to enhance the development and manufacturing of targeted therapeutics.

AI-Driven R&D The company's utilization of AI-powered design and high-throughput in vivo screening opens avenues to collaborate with computational platform providers or data analytics firms to optimize drug discovery workflows and datasets management.

Strategic Collaborations Recent partnerships with Roche highlight a readiness to engage with large pharmaceutical companies, indicating that similar firms in neurology and neurodegenerative pathways may be valuable clients or partners for expanding the company's portfolio.

Funding Momentum With recent Series A financing of $40 million and ongoing strategic alliances, there is potential for venture capital and investment firms specializing in biotech innovation to support and accelerate commercialization efforts targeting advanced biologics and targeted therapies.

Market Expansion Manifold Bio's positioning in the emerging field of tissue-targeted biologics and recent focus on neurological disease solutions suggest opportunities to introduce specialized lab equipment, CRO services, or therapeutic development partnerships to accelerate growth in these high-demand areas.

Manifold Bio Tech Stack

Manifold Bio uses 8 technology products and services including Kubernetes, Google Hosted Libraries, Benchling, and more. Explore Manifold Bio's tech stack below.

  • Kubernetes
    Containerization
  • Google Hosted Libraries
    Content Delivery Network
  • Benchling
    Health Platform
  • Webflow
    Page Builders
  • Java
    Programming Languages
  • Google
    Search Engines
  • GraphPad Prism
    Visualisation Software
  • Apache
    Web Servers

Media & News

Manifold Bio's Email Address Formats

Manifold Bio uses at least 1 format(s):
Manifold Bio Email FormatsExamplePercentage
First@manifold.bioJohn@manifold.bio
43%
FLast@manifold.bioJDoe@manifold.bio
12%
Last@manifold.bioDoe@manifold.bio
2%
First@manifold.bioJohn@manifold.bio
43%

Frequently Asked Questions

Where is Manifold Bio's headquarters located?

Minus sign iconPlus sign icon
Manifold Bio's main headquarters is located at 201 Brookline Ave, 902 Boston, Massachusetts 02215, US. The company has employees across 1 continents, including North America.

What is Manifold Bio's official website and social media links?

Minus sign iconPlus sign icon
Manifold Bio's official website is manifold.bio and has social profiles on LinkedInCrunchbase.

What is Manifold Bio's SIC code NAICS code?

Minus sign iconPlus sign icon
Manifold Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Manifold Bio have currently?

Minus sign iconPlus sign icon
As of October 2025, Manifold Bio has approximately 50 employees across 1 continents, including North America. Key team members include Chief Scientific Officer: K. S.Head Of Platform: B. D.Co-Founder And Ceo: G. K.. Explore Manifold Bio's employee directory with LeadIQ.

What industry does Manifold Bio belong to?

Minus sign iconPlus sign icon
Manifold Bio operates in the Biotechnology Research industry.

What technology does Manifold Bio use?

Minus sign iconPlus sign icon
Manifold Bio's tech stack includes KubernetesGoogle Hosted LibrariesBenchlingWebflowJavaGoogleGraphPad PrismApache.

What is Manifold Bio's email format?

Minus sign iconPlus sign icon
Manifold Bio's email format typically follows the pattern of First@manifold.bio. Find more Manifold Bio email formats with LeadIQ.

How much funding has Manifold Bio raised to date?

Minus sign iconPlus sign icon
As of October 2025, Manifold Bio has raised $40M in funding. The last funding round occurred on Jun 13, 2022 for $40M.

Manifold Bio

Biotechnology ResearchUnited States11-50 Employees

Manifold Bio is positioned to be the leading tissue-specific medicines company. 

We’ve built the first high-throughput in vivo (HTV) discovery engine - combining massively multiplexed in vivo screening and AI-powered design to create targeted biologics. Our engine sculpts pharmacokinetics, biodistribution, and other key properties of biologics directly in living systems, solving previously intractable challenges for tissue-specific delivery. 

By generating rich, scalable datasets in vivo, Manifold Bio is unlocking AI’s full potential to design targeted, effective therapeutics, and accelerate their path to patients.

Section iconCompany Overview

Headquarters
201 Brookline Ave, 902 Boston, Massachusetts 02215, US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $40M

    Manifold Bio has raised a total of $40M of funding over 3 rounds. Their latest funding round was raised on Jun 13, 2022 in the amount of $40M.

  • $25M$50M

    Manifold Bio's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $40M

    Manifold Bio has raised a total of $40M of funding over 3 rounds. Their latest funding round was raised on Jun 13, 2022 in the amount of $40M.

  • $25M$50M

    Manifold Bio's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.